The combination with Allergan, have created a stronger, more diverse company with robust cash flows, and multiple new growth vehicles for the long term. The company now have the leading franchise which is demonstrating a strong V-shape recovery, as well as a highly attractive neuroscience portfolio that delivered double-digit growth on a comparable operational basis […]